findmyKOL

Michael Pincus, DO

Basic profile

Lahey Medical Center

ORCIDNone on fileNPI
RegionBurlington, MA · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Pincus is a Rheumatology/Immunology physician affiliated with Lahey Medical Center. OpenAlex indexes 7 publications with 2,247 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

2,247citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

41 Mall Rd
Lahey Clinic
Burlington, MA 018050001

Telephone

781-744-8000

Registry record last updated 5 Sept 2013.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    45.1%
    Folate Analog Metabolic Inhibitor25.6%
    Methotrexate96%Otrexup3%Methotrexate Sodium2%
    Part D<11 patients
    TNF inhibitor6.5%
    Humira(Cf) Pen42%Enbrel Mini25%Enbrel Sureclick18%Cyltezo(Cf) Pen8%Humira(Cf)7%
    Part D<11 patients

    + 6 more classes in this area

  • Musculoskeletal

    17.3%
    Xanthine oxidase inhibitor11%
    Allopurinol94%Febuxostat6%
    Part D<11 patients
    Muscle Relaxant2.3%
    Cyclobenzaprine Hcl100%
    Part D23 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    14.1%
    Corticosteroid10.5%
    Prednisone100%
    Part D99 patients
    Antidiarrheal microorganisms2.4%
    Folic Acid100%
    Part D27 patients

    + 2 more classes in this area

Where care is delivered (Part B)70.7% facility · 29.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”